1 Min Read
March 24 (Reuters) - Cipla Ltd:
* Cipla Ltd clarifies on news item "USFDA issued import alert on Cipla's Tadalafil drug made at Bhagwanpur unit"
* Says co does not directly or indirectly import for sale or sell Tadalafil tables in US market
* Says co not authorised any party to import for sale or sell Tadalafil tables in US market
* Co is not associated with referenced import alert of Tadalafil product or its source at Bhagwanpur site for US market
* The event has no impact on Cipla Source text: bit.ly/2nOrfSo Further company coverage: